JANEL JESBERGER: Open Payments
NPI 1760928204 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,604 in 68 payments from 21 companies in 2025. Trend: 2023 $1,415 · 2024 $5,326 · 2025 $1,604
Food & beverage: $1,604
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $376 |
| Alexion Pharmaceuticals, Inc. | 4 | $201 |
| LivaNova USA, Inc. | 3 | $154 |
| Novartis Pharmaceuticals Corporation | 12 | $152 |
| EMD Serono, Inc. | 2 | $123 |
| ABBVIE INC. | 4 | $83 |
| Biogen, Inc. | 3 | $66 |
| SK Life Science, Inc. | 2 | $63 |
| Neurelis, Inc. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
Products named: ULTOMIRIS, NURTEC ODT, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, KESIMPTA, PANZYGA, Mavenclad, ZAVZPRET, QULIPTA.
Industry payments across PA — which companies pay providers there.
